Skip to content
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Visit
Home
(current)
Diseases
Parkinson's Disease
Multiple Sclerosis and Related Disorders
Headache
Amyotrophic Lateral Sclerosis
Epilepsy
Sleep Disorders
Stroke
Neuromuscular Disorders
Movement Disorders
View all Diseases
Topics
Biology
Diagnostics
Trial Updates
Treatment
Prevention
Surgery
Imaging
Genetics
COVID-19
View all Topics
Conferences
EEC 2022
EAN 2022
AHS 2022
CMSC 2022
ESOC 2022
AAN 2022
View all Conferences
Features
Podcasts
About
Supporter
Expert Index
Editorial Board
Editorial Team
Editorial Policy
Contact
Sign up
Richard Lipton
1:30
Future work on rimegepant for migraines
Richard Lipton
• 13 Jun 2022
3:26
Zavegepant: an acute treatment option for migraine
Richard Lipton
• 13 Jun 2022
1:59
The current regulatory status of PROMs for clinical trials in migraine
Richard Lipton
• 13 Jun 2022
1:12
The MiCOAS project in migraine
Richard Lipton
• 13 Jun 2022
3:09
Open-label extension study of rimegepant for acute and preventive migraine treatment
Richard Lipton
• 13 Jun 2022
3:03
How to effectively incorporate PROMs into migraine clinical practice and trials
Richard Lipton
• 13 Jun 2022